Amyloidosis Clinical Trials

A listing of Amyloidosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

San Francisco California 94143

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

UPDATED

San Francisco California 94158

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

UPDATED

San Francisco California 94143

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

UPDATED

Stanford California 94305

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

UPDATED

Stanford California 94305

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Colorado

UPDATED

Aurora Colorado 80045

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Connecticut

UPDATED

New Haven Connecticut 06510

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Florida

UPDATED

Miami Florida 33136

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Illinois

UPDATED

Chicago Illinois 60637

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Chicago Illinois 60611

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Chicago Illinois 60637

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Chicago Illinois 60611

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

View More ▼

UPDATED

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

UPDATED

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

UPDATED

Oak Lawn Illinois 60453

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Oak Lawn Illinois 60453

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Louisiana

UPDATED

New Orleans Louisiana 70121

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Maryland

UPDATED

Baltimore Maryland 21205

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Baltimore Maryland 21201

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Baltimore Maryland 21205

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Baltimore Maryland 21201

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Baltimore Maryland 21201

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

View More ▼

UPDATED

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

UPDATED

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Michigan

UPDATED

Ann Arbor Michigan 48109

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Ann Arbor Michigan 48109-5853

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

UPDATED

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Minnesota

UPDATED

Rochester Minnesota 55905

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Rochester Minnesota 55902

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

UPDATED

Rochester Minnesota 55905

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

New Jersey

UPDATED

Newark New Jersey 07112

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

New York

UPDATED

Bronx New York 10461

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

New York New York 10034

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

New York New York 10034

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

New York New York 10032

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

New York New York 10034

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

View More ▼

UPDATED

New York New York 10032

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

North Carolina

UPDATED

Durham North Carolina 27710

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Ohio

UPDATED

Cleveland Ohio 44195

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

UPDATED

Columbus Ohio 43210

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Pennsylvania

UPDATED

Philadelphia Pennsylvania 19104

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Philadelphia Pennsylvania 19104

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Philadelphia Pennsylvania 19104

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

UPDATED

Pittsburgh Pennsylvania 15212

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

View More ▼

UPDATED

Pittsburgh Pennsylvania 15212

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

Tennessee

UPDATED

Nashville Tennessee 37232

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Nashville Tennessee 37232

A clinical research study of None. Observational Study. for the treatment of Transthyretin Mutations or Transthyretin Amyloidosis

UPDATED

Nashville Tennessee 37232

Patients are needed to participate in a clinical research study evaluating Tafamidis meglumine for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy